Greenwich LifeSciences(GLSI) - 2025 Q1 - Quarterly Report

Washington, D.C. 20549 UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☒ QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2025 ☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to COMMISSION FILE NUMBER 001-39555 GREENWICH LIFESCIENCES, INC. Form 10-Q (Exact Name of registrant as specified in its charter) (Mark One) (Address of principal executive offices) (Zip Code) ( ...